According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.
The institute has also been awarded additional funding from the National Institutes of Health for its increased participation in the initiative.
Scientists led by the Scripps Research Institute's Benjamin Cravatt have developed probes and a mass spec method to find methyltransferases in human cells.
Scripps' Gerald Joyce and David Horning have created an RNA polymerase that can replicate short RNA templates faster and create more complex RNA structures than ever before.
The Human Immunome Program, which is part of the Human Vaccines Project, eventually plans to profile B-cell and T-cell receptors in more than 1,000 individuals.
Over the next half year, iGenomX plans to roll out its sequencing library prep chemistry for linked read sequencing.
An analysis of samples taken a year after kidney transplant identified overlapping gene expression signatures associated with acute and chronic rejection.
A paper finds that heating in gas chromatography-mass spectrometry analysis may alter sample compounds, drawing criticism.
The partners will continue to develop and collaborate on the PluriTest software to improve the quality control of human induced pluripotent stem cell lines.
Peter Schultz and Steve Kay are to lead the Scripps Research Institute, according to Nature News.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.